Nuvectis Pharma Closes Stock Offering, Says Underwriter Exercised Overallotment Option

MT Newswires Live
02-07

Nuvectis Pharma (NVCT) said Friday it closed its public offering of 2.7 million shares, with the underwriter exercising in full the option to buy 405,000 additional shares at $5 per share, boosting gross proceeds to about $15.5 million.

The company said it expects to use the net proceeds from the offering to continue clinical development of its NXP800 and NXP900 product candidates, hire additional personnel, and for capital expenditures and other general corporate purposes.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10